Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized phase 2 trial of carboplatin with or without paclitaxel in vulnerable elderly women with advanced ovarian cancer
2013-000266-11Phase 2Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Jun 2013
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of carboplatin and paclitaxel in ovarian cancer (3 arms), sponsored by Hospices Civils de Lyon. Primary endpoint: Success rate of chemotherapy delivery. Started Jun 2013; status: completed.
02
Drugs
carboplatinpaclitaxel
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on 2013-000266-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000266-11.